Sp44
GASTRITIS, ATROPHY AND METAPLASIA: A PATHOLOGISTS PERPECTIVE
Date
May 6, 2023
Explore related products in the following collection:
Society: AGA
Gastritis is frequently encountered by gastroenterologists in their evaluation of patients with foregut-related symptoms. There is an unmet need for GI clinicians to become familiar with the many types of gastritis given the several etiologies present, and the implications for treatment, prognosis, and surveillance. Gastric metaplasia, although uncommon in US populations, presents a quandary for practicing physicians given the general unfamiliarity with its classification, management and prognosis. Several novel endoscopic techniques have been proposed to improve the diagnosis of gastric preneoplastic lesions and help personalize and guide the most appropriate surveillance strategy. The purpose of this session is thus to familiarize clinicians with how to approach and manage the patient with gastritis and/or gastric atrophy/metaplasia with the aim of obtaining a definitive diagnosis, staging and grading the lesion, identifying the likely etiologic factor, and initiating appropriate treatment and surveillance.
Gastritis is frequently encountered by gastroenterologists in their evaluation of patients with foregut-related symptoms. There is an unmet need for GI clinicians to become familiar with the many types of gastritis given the several etiologies present, and the implications for treatment, prognosis, and surveillance. Gastric metaplasia, although uncommon in US populations, presents a quandary for practicing physicians given the general unfamiliarity with its classification, management and prognosis. Several novel endoscopic techniques have been proposed to improve the diagnosis of gastric preneoplastic lesions and help personalize and guide the most appropriate surveillance strategy. The purpose of this session is thus to familiarize clinicians with how to approach and manage the patient with gastritis and/or gastric atrophy/metaplasia with the aim of obtaining a definitive diagnosis, staging and grading the lesion, identifying the likely etiologic factor, and initiating appropriate treatment and surveillance.
Presenter
Miraca Life Sciences
Tracks
Related Products
HABITUAL MEAT INTAKE IS ASSOCIATED WITH INCREASED RISK OF DISEASE FLARE IN ULCERATIVE COLITIS: INITIAL RESULTS FROM THE PREDICCT STUDY
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
ENCAPSULATED MICROBIOTA TRANSPLANT THERAPY IMPROVES PARTIAL MAYO SCORES IN ULCERATIVE COLITIS AND INDUCES RAPID ENGRAFTMENT COMPARED TO PLACEBO CONTROL
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
AGA Kristin and David Peura, MD, Lecture: Diagnosis and Management of Chronic Gastritis and Its Neoplastic Sequelae
Gastritis is frequently encountered by gastroenterologists in their evaluation of patients with foregut-related symptoms…
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
